The COVID-19 outbreak caused an unprecedented burden on the healthcare system at a global level. To fight this pandemic, testing, tracking, and tracing were of crucial importance, but limited resources often jeopardized screening programs. Copan LolliSponge™ has been developed in collaboration with the University of Milan to allow saliva collection from non-collaborative patients or when professional assistance is unavailable. This enabled COVID-19 active surveillance programs in fragile communities.
In this second Copan White Paper, we describe in detail all the necessary steps to collect saliva for SARS-CoV-2 detection with LolliSponge™ and analyze its use, processing, and performance in the lab.
Read the full document at the link below: